| Exosome as a novel shuttle for delivery of therapeutics across biological barriers CK Das, BC Jena, I Banerjee, S Das, A Parekh, SK Bhutia, M Mandal Molecular pharmaceutics 16 (1), 24-40, 2018 | 200 | 2018 |
| Molecular targeting of Akt by thymoquinone promotes G1 arrest through translation inhibition of cyclin D1 and induces apoptosis in breast cancer cells S Rajput, BNP Kumar, KK Dey, I Pal, A Parekh, M Mandal Life sciences 93 (21), 783-790, 2013 | 161 | 2013 |
| Lactate dehydrogenase A regulates autophagy and tamoxifen resistance in breast cancer CK Das, A Parekh, PK Parida, SK Bhutia, M Mandal Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1866 (6), 1004-1018, 2019 | 97 | 2019 |
| Celecoxib alleviates tamoxifen-instigated angiogenic effects by ROS-dependent VEGF/VEGFR2 autocrine signaling BNP Kumar, S Rajput, KK Dey, A Parekh, S Das, A Mazumdar, M Mandal Bmc Cancer 13, 1-15, 2013 | 84 | 2013 |
| Multi-nucleated cells use ROS to induce breast cancer chemo-resistance in vitro and in vivo A Parekh, S Das, S Parida, CK Das, D Dutta, SK Mallick, PH Wu, ... Oncogene 37 (33), 4546-4561, 2018 | 80 | 2018 |
| Gold nanorod embedded reduction responsive block copolymer micelle-triggered drug delivery combined with photothermal ablation for targeted cancer therapy S Parida, C Maiti, Y Rajesh, KK Dey, I Pal, A Parekh, R Patra, D Dhara, ... Biochimica et Biophysica Acta (BBA)-General Subjects 1861 (1), 3039-3052, 2017 | 73 | 2017 |
| Bioimpedimetric analysis in conjunction with growth dynamics to differentiate aggressiveness of cancer cells A Parekh, D Das, S Das, S Dhara, K Biswas, M Mandal, S Das Scientific reports 8 (1), 783, 2018 | 44 | 2018 |
| Therapeutic implication of ‘Iturin A’for targeting MD-2/TLR4 complex to overcome angiogenesis and invasion G Dey, R Bharti, PK Ojha, I Pal, Y Rajesh, I Banerjee, P Banik, S Parida, ... Cellular signalling 35, 24-36, 2017 | 39 | 2017 |
| GW627368X inhibits proliferation and induces apoptosis in cervical cancer by interfering with EP4/EGFR interactive signaling S Parida, I Pal, A Parekh, B Thakur, R Bharti, S Das, M Mandal Cell death & disease 7 (3), e2154-e2154, 2016 | 35 | 2016 |
| Glucose directly promotes antifungal resistance in the fungal pathogen, Candida spp. SM Mandal, D Mahata, L Migliolo, A Parekh, PS Addy, M Mandal, A Basak Journal of Biological Chemistry 289 (37), 25469-25473, 2014 | 33 | 2014 |
| Identification of RAB2A and PRDX1 as the potential biomarkers for oral squamous cell carcinoma using mass spectrometry-based comparative proteomic approach KK Dey, I Pal, R Bharti, G Dey, BNP Kumar, S Rajput, A Parekh, S Parida, ... Tumor Biology 36, 9829-9837, 2015 | 28 | 2015 |
| Molecular inhibition of prostaglandin E2 with GW627368X: Therapeutic potential and preclinical safety assessment in mouse sarcoma model S Parida, A Parekh, G Dey, SC Ghosh, M Mandal Cancer biology & therapy 16 (6), 922-932, 2015 | 15 | 2015 |
| Wavelet-based multiscale analysis of bioimpedance data measured by electric cell-substrate impedance sensing for classification of cancerous and normal cells D Das, K Shiladitya, K Biswas, PK Dutta, A Parekh, M Mandal, S Das Physical Review E 92 (6), 062702, 2015 | 14 | 2015 |
| A novel computational predictive biological approach distinguishes Integrin β1 as a salient biomarker for breast cancer chemoresistance S Das, M Kundu, A Hassan, A Parekh, BC Jena, S Mundre, I Banerjee, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1869 (6), 166702, 2023 | 6 | 2023 |
| Cancer stem cell induces chemoresistance in breast cancer via macrophage migration inhibitory factor mediated activation of AKT pathway S Das, M Kundu, A Parekh, D Bharadwaj, M Mandal Cancer Research 79 (13_Supplement), 4676-4676, 2019 | 2 | 2019 |
| Progressing towards a human-centric approach in cancer research A Parekh, S Das, CK Das, M Mandal Frontiers in Oncology 12, 896633, 2022 | 1 | 2022 |
| Polyploid giant cancer cells induce growth arrest and cytoskeletal rearrangement in breast cancer cells D Bharadwaj, A Parekh, S Das, BC Jena, M Mandal New Biotechnology 44, S141, 2018 | 1 | 2018 |
| Targeting ECM via stress associated regulation: A potential therapeutic avenue for overcoming temozolamide resistance in glioblastoma A Biswas, R Yetirajam, S Das, A Parekh, M Mandal New Biotechnology 44, S141-S142, 2018 | 1 | 2018 |
| Parkin-mediated mitophagy regulates 5-fluorouracil-induced chemoresistance in breast cancer CK Das, BC Jena, S Das, A Parekh, G Dey, R Bharti, D Bharadwaj, ... Cancer Research 78 (13_Supplement), 1348-1348, 2018 | 1 | 2018 |
| Integrin β1 regulates doxorubicin resistance in breast cancer via FAK-mediated activation of ERK1 pathway S Das, BC Jena, S Mundre, A Parekh, Y Rajesh, P Mitra, M Mandal Cancer Research 78 (13_Supplement), 4022-4022, 2018 | 1 | 2018 |
Mahitosh MandalProfessor, School of Medical Science and Technology,Indian Institute of Technology, Kharagpur, India在 smst.iitkgp.ac.in 的电子邮件经过验证
